BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36424703)

  • 1. Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ.
    Liu J; Wang Y; Wan X; Zou J; Zhu Y; Lv W; Shen Y
    J Gynecol Oncol; 2023 Jan; 34(1):e8. PubMed ID: 36424703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
    Huang SS; Sui L; Chen LM; Zhang HW; Tao X
    Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of loop electrosurgical excisional procedure in diagnosis and treatment of cervical adenocarcinoma in situ and invasive cervical adenocarcinoma].
    Song Y; Wang Q; Sui L; Gao SJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):178-182. PubMed ID: 29609232
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.
    Codde E; Munro A; Stewart C; Spilsbury K; Bowen S; Codde J; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Cohen PA
    BJOG; 2018 Jan; 125(1):74-79. PubMed ID: 28678394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
    Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
    Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between various histological status of margins of LEEP and residual HSIL or worse at hysterectomy following conization].
    Xiao YP; Tao X; Zhao CY; Qu YQ; Xie F; Ning Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jan; 54(1):19-23. PubMed ID: 30695901
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
    Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
    Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses.
    Maluf PJ; Adad SJ; Murta EF
    Tumori; 2004; 90(5):473-7. PubMed ID: 15656332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
    Tan JHJ; Malloy MJ; Thangamani R; Gertig D; Drennan KT; Wrede CD; Saville M; Quinn M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):123-129. PubMed ID: 31578727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer.
    Wong AS; Li WH; Cheung TH
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():21-6. PubMed ID: 26894378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triage for management of cervical high-grade squamous intraepithelial lesion patients with positive margin by conization: a retrospective analysis.
    Dou Y; Zhang X; Li Y; Wang F; Xie X; Wang X
    Front Med; 2017 Jun; 11(2):223-228. PubMed ID: 28488232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization.
    Kim WY; Chang SJ; Chang KH; Yoo SC; Ryu HS
    Int J Gynaecol Obstet; 2010 May; 109(2):110-2. PubMed ID: 20096835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Hartman CA; Teixeira JC; Barbosa SB; Figueiredo SM; Andrade LA; Bastos JF
    Int J Gynecol Cancer; 2017 Feb; 27(2):357-363. PubMed ID: 27984378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
    Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
    Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.